These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7996306)

  • 1. RU 486: an alternative to surgical abortion.
    Donaldson K; Briggs J; McMaster D
    J Obstet Gynecol Neonatal Nurs; 1994 Sep; 23(7):555-9. PubMed ID: 7996306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RU 486, mifepristone: a review of a controversial drug.
    DiPierri D
    Nurse Pract; 1994 Jun; 19(6):59-61. PubMed ID: 8065661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review.
    Avrech OM; Golan A; Weinraub Z; Bukovsky I; Caspi E
    Fertil Steril; 1991 Sep; 56(3):385-93. PubMed ID: 1894013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mifepristone (RU 486) for induced abortion.
    Grimes DA
    Womens Health Issues; 1993; 3(3):171-5. PubMed ID: 8274873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy interruption using mifepristone (RU-486). A new choice for women in the USA.
    Mackenzie SJ; Yeo S
    J Nurse Midwifery; 1997; 42(2):86-90. PubMed ID: 9107115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RU-486: legal and policy issues confronting the Food and Drug Administration.
    Muhl C
    J Leg Med; 1993 Jun; 14(2):319-47. PubMed ID: 8340714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigestogens.
    Baird DT
    Br Med Bull; 1993 Jan; 49(1):73-87. PubMed ID: 8324617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiprogestin drugs: ethical, legal and medical issues.
    Cook RJ; Grimes DA
    Law Med Health Care; 1992; 20(3):149-53. PubMed ID: 1434754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mifepristone (RU 486) in the United States. What does the future hold?
    Rosenfield A
    N Engl J Med; 1993 May; 328(21):1560-1. PubMed ID: 8479494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mifepristone (RU486): a review.
    Mahajan DK; London SN
    Fertil Steril; 1997 Dec; 68(6):967-76. PubMed ID: 9418681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RU 486: an overview of mifepristone and its potential applications.
    Contracept Rep; 1993 May; 4(2):7-9. PubMed ID: 12286473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized clinical trial of mifepristone (RU486) for induction of delayed menses: efficacy and acceptability.
    Grimes DA; Mishell DR; David HP
    Contraception; 1992 Jul; 46(1):1-10. PubMed ID: 1424618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RU 486 approved in Britain; U.S. research still limited.
    Contracept Technol Update; 1991 Sep; 12(9):144-7. PubMed ID: 12317312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RU 486 story: the French experience.
    Sharts-Engel NC
    MCN Am J Matern Child Nurs; 1992; 17(1):56. PubMed ID: 1738308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiprogesterone steroid RU 486: a short pharmacological and clinical review, with emphasis on the interruption of pregnancy.
    Garfield RE; Baulieu EE
    Baillieres Clin Endocrinol Metab; 1987 Feb; 1(1):207-21. PubMed ID: 3297023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiprogestin drugs: ethical issues.
    Macklin R
    Law Med Health Care; 1992; 20(3):215-9. PubMed ID: 1434763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RU 486: how abortion politics have impacted on a potentially useful drug of broad medical application.
    Regelson W
    Perspect Biol Med; 1992; 35(3):330-8. PubMed ID: 1501996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boycott threat forces French company to abandon RU486.
    Dorozynski A
    BMJ; 1997 Apr; 314(7088):1150. PubMed ID: 9146386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RU-486 and the politics of reproduction.
    Rosenfield A
    Female Patient; 1989 Mar; 14(3):69, 73-4. PubMed ID: 12342816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.